# Chemokine and Co-stimulatory Molecule-modified Mesenchymal Stem Cells for the Treatment of Advanced Colorectal Cancer

> **NCT06446050** · EARLY_PHASE1 · RECRUITING · sponsor: **Shanghai East Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Advanced Colorectal Cancer

## Interventions

- **BIOLOGICAL:** MSC-L

## Key facts

- **NCT ID:** NCT06446050
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-21
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06446050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06446050, "Chemokine and Co-stimulatory Molecule-modified Mesenchymal Stem Cells for the Treatment of Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06446050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*